Kenneth A. Clark

Insider Reports History

Entity
Individual
Location
C/O Pharmacyclics, Inc., 995 East Arques Ave., Sunnyvale, CA
Signature
/s/ Ankur Dhingra, as Attorney-in-Fact for Kenneth A. Clark
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kenneth A. Clark:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Summit Therapeutics Inc. Director Stock Option (right to buy) 105K $139K $1.32 Jan 2, 2024 Direct
Pulse Biosciences, Inc. Director Stock Option (right to buy) 8.03K May 20, 2021 Direct

Insider Reports Filed by Kenneth A. Clark

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SMMT Summit Therapeutics Inc. Jan 2, 2024 2 $93K 4 Jan 4, 2024 Director
SMMT Summit Therapeutics Inc. Jan 3, 2023 2 $74.1K 4 Jan 5, 2023 Director
SMMT Summit Therapeutics Inc. Jan 3, 2022 2 $66.1K 4 Jan 5, 2022 Director
SMMT Summit Therapeutics Inc. Oct 7, 2021 2 $0 4 Oct 12, 2021 Director
SMMT Summit Therapeutics Inc. Oct 7, 2021 0 $0 3 Oct 12, 2021 Director
PLSE Pulse Biosciences, Inc. May 20, 2021 2 $0 4 May 21, 2021 Director